PIN5C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
**Preservative:** 0.03% Proclin 300
**Constituents:** 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
PIN5C antibody; Os08g0529000 antibody; LOC_Os08g41720 antibody; OJ1770_H02.15 antibody; Probable auxin efflux carrier component 5c antibody; OsPIN5c antibody; OsPIN5b antibody
Target Names
PIN5C
Uniprot No.

Target Background

Function
PIN5C Antibody may function as a component of the auxin efflux carrier.
Database Links
Protein Families
Auxin efflux carrier (TC 2.A.69.1) family
Subcellular Location
Membrane; Multi-pass membrane protein.
Tissue Specificity
Expressed in roots, leaves, shoot apex and panicles.

Q&A

Basic Research Questions

  • What is PIN5C antibody and what specific targets does it recognize?

    PIN5C antibody is a polyclonal antibody cocktail designed for diagnostic pathology that combines detection of multiple key prostate markers: p504S (AMACR), p40, and high molecular weight cytokeratin. This antibody combination operates on a dual-marker principle where p504S functions as a positive marker for prostatic carcinoma, while p40 and high molecular weight cytokeratin serve as negative markers (identifying basal cells present in benign conditions but absent in carcinoma).

    The p504S component targets alpha-methylacyl-CoA racemase, which is overexpressed in prostate cancer cells but minimally expressed in benign prostatic tissue. The p40 component (an isoform of p63) and high molecular weight cytokeratin markers specifically target basal epithelial cells, which form a continuous layer in benign prostate tissue but are absent in prostate carcinomas .

  • How should I validate PIN5C antibody before incorporating it into my experimental protocol?

    Validating PIN5C antibody requires a comprehensive multi-approach strategy:

    • Implement a binary validation approach by testing the antibody in both positive and negative expression systems

    • Test using endogenous controls (tissues with known expression patterns)

    • Verify results using orthogonal methods such as genetic sequencing or proteomic profiling

    • Validate the antibody specifically for each application where it will be used (IHC, IF, etc.)

    • Compare staining patterns with previously validated antibodies targeting the same proteins

    • Test reproducibility using different antibody lots over time

    • Document all validation procedures thoroughly in your laboratory notes

    For PIN5C specifically, validation should include testing on known positive cases (confirmed prostate cancer tissues) and negative controls (benign prostate tissues with intact basal cell layers). When examining antibody specificity, remember that a single validation approach is insufficient - Cell Signaling Technology recommends combining multiple validation strategies for each antibody .

  • What control samples are essential when using PIN5C antibody in tissue analysis?

    Proper controls are critical for accurate interpretation of PIN5C antibody results:

    Control TypeDescriptionPurpose
    Positive tissue controlConfirmed prostate cancer tissueShould show p504S expression with absence of basal markers
    Negative tissue controlBenign prostate tissueShould show basal cell marker expression with minimal p504S
    Internal controlAreas within the same tissue sectionCompare suspected cancer with adjacent normal tissue
    Isotype controlMatched immunoglobulin isotypeIdentify non-specific binding
    Technical controlsOmission of primary antibodyCheck for non-specific binding of detection systems

    Every experiment should include both positive and negative controls to assess antibody performance, ideally using samples with variable expression levels of the protein of interest . This approach allows validation of antibody specificity and helps identify technical issues in the staining protocol.

  • How do I interpret PIN5C antibody staining patterns in prostate specimens?

    Proper interpretation requires evaluating the pattern of both marker types in conjunction:

    • Prostate cancer: Positive for p504S (AMACR) component and negative for basal cell markers (p40 and HMW cytokeratin)

    • Benign prostate tissue: Negative or weakly positive for p504S (AMACR) and positive for basal cell markers showing a continuous layer

    • High-grade PIN: Often positive for p504S (AMACR) while still retaining some basal cells (discontinuous basal layer)

    • Atypical adenomatous hyperplasia: May show variable staining patterns

    The PIN5 antibody combination is particularly useful for confirming prostate carcinoma diagnosis in small foci of needle biopsies where tissue may be limited. The positive prostate cancer marker (p504S) in conjunction with the negative basal cell markers offers utility in diagnosing PIN in difficult cases .

  • What factors affect PIN5C antibody sensitivity and specificity in immunohistochemistry?

    Multiple variables can significantly impact PIN5C antibody performance:

    • Pre-analytical factors: Fixation type, duration, and tissue processing methods

    • Analytical factors: Antigen retrieval method, pH of retrieval buffer, antibody dilution, incubation time and temperature

    • Detection system: Chromogen choice, amplification methods, counterstain

    • Tissue characteristics: Age of blocks, antigen preservation, tissue type

    • Technical execution: Staining technique variability, manual vs. automated platforms

    To optimize sensitivity and specificity, systematically test different conditions, keeping all other variables constant while changing one parameter at a time. Document optimal conditions that produce the highest signal-to-noise ratio while maintaining specific staining patterns .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.